Health Care/Hospital

Soul App Motivates Gen Z to Help People Suffering from Mental Disorders, Injecting Young Energy into Social Good

SHANGHAI, March 5, 2021 /PRNewswire/ -- As a social networking platform that champions a genuine, diverse, and inclusive culture and stands for social good, Soul App has rolled out a series of events for the benefit of the public, especially the vulnerable, and continues to promote to its young u...

2021-03-05 19:00 3213

Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy

STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy,Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration.Monaco brings robust functionality for proton therapy, featurin...

2021-03-05 15:19 5432

DFRobot's HuskyLens, an AI Vision Sensor, included in the "forget-me-not" for Alzheimer's patients

SHANGHAI, March 4, 2021 /PRNewswire/ -- Alzheimer's disease is a common syndrome among older people worldwide. InChina, there are about 10 million Alzheimer's patients by now, ranking first in the world. By 2050, the number of Alzheimer's patients inChina is estimated to reach 45 million. Lu Yu...

2021-03-05 14:14 2672

Mayne Pharma launches another generic oral contraceptive

ADELAIDE, Australia, March 4, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US. This is the fourth oral contraceptive la...

2021-03-05 05:34 5242

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 5296

Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States

TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals ("Intas") for the US commercialization of Foresee's novel FP-001 program, Leuprolide Mesylate Injectable Suspensi...

2021-03-04 23:00 3605

Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite

SEOUL, South Korea, March 4, 2021 /PRNewswire/ -- Lunit , a leading medical AI startup, today announced its partnership withPhilips . Announced during the  European Congress of Radiology (ECR)

2021-03-04 17:00 1972

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 3743

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...

2021-03-04 09:00 3562

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

LONDON, March 4, 2021 /PRNewswire/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also c...

2021-03-04 08:01 2690

Founder of NutriBullet®* Launches Wellness Brand - Beast Health™ - and its Design-Forward Blender and Hydration System

Groundbreaking Product is First of Several Planned Launches from Beast Health, LLC LOS ANGELES, March 3, 2021 /PRNewswire/ -- Colin Sapire, founder of the NutriBullet®* and innovator behind personal blending products for more than a decade, announces the launch of wellness brand Beast Healt...

2021-03-03 23:02 2546

Yuyu Pharma Publishes History for 80th Anniversary

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu), in anticipation of the 80th anniversary of its establishment onFebruary 28th, 2021, published its history of challenges and changes over the past 80 years. The history is told in storytelling forma...

2021-03-03 22:00 2452

WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods Administration

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Wellmarker Bio(www.wmbio.co ) announced that on February 23, 2021 the company received approval from the Australian Therapeutic Goods Administration (TGA) for a Phase I clinical trial using WM-S1-030, a targeted anti-cancer d...

2021-03-03 22:00 2192

I-Mab to Report Financial Results for the Full Year 2020 and Provide Corporate Update on March 29, 2021

SHANGHAI and GAITHERSBURG, Md., March 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the full year ...

2021-03-03 21:00 5600

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the European Medicines Agency (EMA) has completed a remote Pre-Approval Inspection (PAI) on its drug substance facility ...

2021-03-03 18:23 2553

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange

SHANGHAI, March 3, 2021 /PRNewswire/ -- SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") was officially listed today on the Main Board of The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange" or "HKEx") under stock code: 6600. In the initial of...

2021-03-03 16:43 8048

AXA extends holistic wellness platform "AXA BetterMe" to all Employee Benefits customers

HONG KONG, March 3, 2021 /PRNewswire/ -- With COVID vaccination becoming available inHong Kong, many corporates are getting ready to accelerate their business activities again. As a leading Employee Benefits insurer inHong Kong, AXA Hong Kong andMacau has already taken the lead to support its Emp...

2021-03-03 14:15 2394

Biotheus Announces the Closing of a New Round of Financing co-led by General Atlantic and IDG Capital

ZHUHAI, China, March 2, 2021 /PRNewswire/ -- Biotheus has announced the successful completion of a fourth round of financing, co-led by General Atlantic, a leading global growth equity investor, and IDG Capital, a global leading investment firm. Other new investors include Kunlun Capital, CPE, an...

2021-03-03 11:37 1799

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project

SUZHOU, China, March 2, 2021 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc ("CMAB") congratulates its partner Innovent Biologics, Inc ("Innovent") (1801.HK) on the U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for its antibody candidate which ta...

2021-03-03 11:12 1790

Telemedicine platform HiDoc launches Nectar, a community app dedicated to women's health and wellness

* Following a spike in the number of teleconsultations and enquiries from the women's community during the circuit breaker period, HiDoc created Nectar, a web-based application to inspire a new generation of women to achieve optimal health * Prominent features of the app include Nectar's Ask ...

2021-03-03 10:00 3667
1 ... 829830831832833834835 ... 858